Canaccord conducts a sensitivity analysis of the Israeli pharmaceutical firm InterCure's (INCR) estimated share price in figure 33 on page 30:
Estimate the Macaulay duration of INCR's equity. The Macaulay duration is approximately:
Canaccord conducts a sensitivity analysis of the Israeli pharmaceutical firm InterCure's (INCR) estimated share price in figure 33 on page 30:
Estimate the Macaulay duration of INCR's equity. The Macaulay duration is approximately: